Global Burden of Thyroid Cancer

doi:10.12114/j.issn.1007-9572.2018.00.174

Abstract

Abstract: Thyroid cancer is the fastest growing malignancy throughout the world in recent years.Its burden varies across different regions due to specific clinical and prognostic features.Moreover，the changes in its trend of burden are mainly attributed to overdiagnosis and overtreatment.In China，local characteristics of burden of thyroid cancer call for further investigations in etiology，economic and clinical management with native data.

Key words: Thyroid neoplasms, Cost of illness, Incidence, Epidemiology, Quality of life

摘要： 甲状腺癌是近年来全球范围内发病率增长最快的恶性肿瘤。但以其特殊的临床和预后特点，甲状腺癌的疾病负担在全球范围内的变迁并非均衡。过度诊疗在全球甲状腺癌的疾病负担特征变迁上起到了重要的作用。但我国甲状腺癌的疾病负担也有其独特之处，提示我国甲状腺癌在病因、卫生经济学和治疗策略选择方面需要更多本土化研究。

关键词: 甲状腺肿瘤, 患病代价, 发病率, 流行病学, 生活质量

LI Fei,LI She-yu. Global Burden of Thyroid Cancer[J]. Chinese General Practice, 2018, 21(26): 3155-3159. DOI: 10.12114/j.issn.1007-9572.2018.00.174.
李斐,李舍予. 全球甲状腺癌疾病负担[J]. 中国全科医学, 2018, 21(26): 3155-3159. DOI: 10.12114/j.issn.1007-9572.2018.00.174.

References

［1］JAN S，LABA T L，ESSUE B M，et al.Action to address the household economic burden of non-communicable diseases［J］.Lancet，2018，391（10134）：2047-2058.DOI：10.1016/S0140-6736（18）30323-4.3158
［2］Global Burden of Disease Cancer Collaboration，FITZMAURICE C，AKINYEMIJU T F，et al.Global，regional，and national cancer incidence，mortality，years of life lost，years lived with disability，and disability-adjusted life-years for 29 cancer groups，1990 to 2016：a systematic analysis for the Global Burden of Disease Study［J］.JAMA Oncol，2018.DOI：10.1001/jamaoncol.2018.2706.3158
［3］ZHENG T，HOLFORD T R，CHEN Y，et al.Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut，1935—1992［J］.Int J Cancer，1996，67（4）：504-509.3158
［4］AHN H S，KIM H J，WELCH H G.Korea's thyroid-cancer “epidemic”—screening and overdiagnosis［J］.N Engl J Med，2014，371（19）：1765-1767.DOI：10.1056/NEJMp1409841.3158
［5］JUNG K W，WON Y J，OH C M，et al.Cancer statistics in Korea：incidence，mortality，survival，and prevalence in 2014［J］.Cancer Res Treat，2017，49（2）：292-305.DOI：10.4143/crt.2017.118.3158
［6］DAVIES L，WELCH H G.Current thyroid cancer trends in the United States［J］.JAMA Otolaryngol Head Neck Surg，2014，140（4）：317-322.DOI：10.1001/jamaoto.2014.1.3158
［7］丛舒，方利文，包鹤龄，等.1990年与2013年中国人群甲状腺癌疾病负担分析［J］.中华流行病学杂志，2016，37（6）：773-777.DOI：10.3760/cma.j.issn.0254-6450.2016.06.006.3159
CONG S，FANG L W，BAO H L，et al.Disease burden of thyroid cancer in the Chinese population，in 1990 and 2013［J］.Chinese Journal of Epidemiology，2016，37（6）：773-777.DOI：10.3760/cma.j.issn.0254-6450.2016.06.006.3159
［8］CHEN W，ZHENG R，BAADE P D，et al.Cancer statistics in China，2015［J］.CA Cancer J Clin，2016，66（2）：115-132.DOI：10.3322/caac.21338.3159
［9］GBD 2016 DALYs and HALE Collaborators.Global，regional，and national disability-adjusted life-years （DALYs） for 333 diseases and injuries and healthy life expectancy （HALE） for 195 countries and territories，1990—2016：a systematic analysis for the Global Burden of Disease Study 2016［J］.Lancet，2017，390（10100）：1260-1344.DOI：10.1016/S0140-6736（17）32130-X.3159
［10］Global Burden of Disease Collaborative Network.Global Burden of Disease Study 2016 （GBD 2016） Results［EB/OL］.（2017）［2018-06-25］.http：//ghdx.healthdata.org/gbd-results-tool.3159
［11］HAUGEN B R，ALEXANDER E K，BIBLE K C，et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer：the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer［J］.Thyroid，2016，26（1）：1-133.DOI：10.1089/thy.2015.0020.3159
［12］LANG B H，WONG C K，CHAN C T.Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer：a health care service provider perspective［J］.Eur J Surg Oncol，2015，41（6）：758-765.DOI：10.1016/j.ejso.2015.01.019.3159
［13］LUBITZ C C，KONG C Y，MCMAHON P M，et al.Annual financial impact of well-differentiated thyroid cancer care in the United States［J］.Cancer，2014，120（9）：1345-1352.DOI：10.1002/cncr.28562.3159
［14］ASCHEBROOK-KILFOY B，SCHECHTER R B，SHIH Y C，et al.The clinical and economic burden of a sustained increase in thyroid cancer incidence［J］.Cancer Epidemiol Biomarkers Prev，2013，22（7）：1252-1259.DOI：10.1158/1055-9965.EPI-13-0242.3159
［15］谢岱仪，王前，李超，等.甲状腺癌患者住院费用影响因素分析［J］.中国医疗保险，2018，11（1）：46-50.DOI：10.19546/j.issn.1674-3830.2018.1.011.3159
XIE D Y，WANG Q，LI C，et al.Analysis of the influencing factors of hospitalization expense of patients with thyroid carcinoma in a hospital［J］.China Health Insurance，2018，11（1）：46-50.DOI：10.19546/j.issn.1674-3830.2018.1.011.3159
［16］HEDMAN C，DJ?RV T，STRANG P，et al.Determinants of long-term quality of life in patients with differentiated thyroid carcinoma-a population-based cohort study in Sweden［J］.Acta Oncol，2016，55（3）：365-369.DOI：10.3109/0284186X.2015.1102965.3159
［17］SINGER S，HUSSON O，TOMASZEWSKA I M，et al.Quality-of-life priorities in patients with thyroid cancer：a multinational European organisation for research and treatment of cancer phase Ⅰ study［J］.Thyroid，2016，26（11）：1605-1613.3159
［18］ROGERS S N，MEPANI V，JACKSON S，et al.Health-related quality of life，fear of recurrence，and emotional distress in patients treated for thyroid cancer［J］.Br J Oral Maxillofac Surg，2017，55（7）：666-673.DOI：10.1016/j.bjoms.2016.09.001.3159
［19］HUSSON O，HAAK H R，MOLS F，et al.Development of a disease-specific health-related quality of life questionnaire （THYCA-QoL） for thyroid cancer survivors［J］.Acta Oncol，2013，52（2）：447-454.DOI：10.3109/0284186X.2012.718445.3159
［20］MOLS F，SCHOORMANS D，SMIT J W A，et al.Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample：results from the PROFILES registry［J］.Head Neck，2018.DOI：10.1002/hed.25325.3159
［21］TAMMINGA S J，BüLTMANN U，HUSSON O，et al.Employment and insurance outcomes and factors associated with employment among long-term thyroid cancer survivors：a population-based study from the PROFILES registry［J］.Qual Life Res，2016，25（4）：997-1005.DOI：10.1007/s11136-015-1135-z.3159
［22］JAMES B C，ASCHEBROOK-KILFOY B，WHITE M G，et al.Quality of life in thyroid cancer-assessment of physician perceptions［J］.J Surg Res，2018，226：94-99.DOI：10.1016/j.jss.2017.11.069.3159
［23］WANG T，JIANG M，REN Y，et al.Health-related quality of life of community thyroid cancer survivors in Hangzhou，China［J］.Thyroid，2018.DOI：10.1089/thy.2017.0213.3159
［24］GOU J，CHENG W，LEI J，et al.Health-related quality-of-life assessment in surgical patients with papillary thyroid carcinoma：a single-center analysis from Mainland China［J］.Medicine（Baltimore），2017，96（38）：e8070.DOI：10.1097/MD.0000000000008070.3159
［25］US Preventive Services Task Force，BIBBINS-DOMINGO K，GROSSMAN D C，et al.Screening for thyroid cancer：US Preventive Services Task Force Recommendation Statement［J］.JAMA，2017，317（18）：1882-1887.DOI：10.1001/jama.2017.4011.3159
［26］ODA H，MIYAUCHI A，ITO Y，et al.Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery［J］.Thyroid，2016，26（1）：150-155.DOI：10.1089/thy.2015.0313.3159
［27］KIM T Y，SHONG Y K.Active surveillance of papillary thyroid microcarcinoma：a mini-review from Korea［J］.Endocrinol Metab （Seoul），2017，32（4）：399-406.DOI：10.3803/EnM.2017.32.4.399.3159

[1]	ZHANG Aili, HOU Qiqi, HAN Quanle, ZHANG Boheng, ZHANG Jiawei, CAO Hongxia, ZHANG Chao, CHEN Shuohua, WU Shouling, LI Kangbo. Correlation between Atrial Fibrillation and the Risk of New-onset Chronic Kidney Disease in Northern Chinese Population [J]. Chinese General Practice, 2023, 26(36): 4521-4526.
[2]	BAO Yunli, WANG Zhe, TANG Hairu, LI Na, ZHENG Ying, LI Bin, MA Jun, YU Xiaohui. Disease Burden and Variation Tendency of Inflammatory Bowel Disease in China from 1990 to 2019 [J]. Chinese General Practice, 2023, 26(36): 4581-4586.
[3]	ZHU Wenpeng, HAN Mengqi, WANG Yuxin, WANG Guoping. Trends and Projections of Incidence and Mortality of Nasopharyngeal Carcinoma in China from 1990 to 2019 [J]. Chinese General Practice, 2023, 26(34): 4269-4276.
[4]	JIA Yu, ZHOU Zitong, CAO Xuehua, HU Wanqin, XIANG Feng, XIONG Langyu, WANG Xiaoxia. Incidence of Perimenopausal Syndrome in Chinese Women Aged 40 to 65 Years: a Meta-analysis [J]. Chinese General Practice, 2023, 26(32): 4080-4088.
[5]	GAO Jing, ZHOU Shangcheng, GAO Sande, ZOU Guanyang, CHEN Yingyao. Health-related Quality of Life and Its Influencing Factors in Patients with Prevention of Disease in Traditionnal Chinese Medicine based on EQ-5D-5L Scale [J]. Chinese General Practice, 2023, 26(32): 4043-4050.
[6]	MA Liyuan, WANG Zengwu, FAN Jing, HU Shengshou. Interpretation of Report on Cardiovascular Health and Diseases in China 2022 [J]. Chinese General Practice, 2023, 26(32): 3975-3994.
[7]	HU Jingyi, HONG Jing, GUO Xiaodong, ZHANG Xiaohong, MO Ning, ZHOU Xiaocui, YU Qin, ZHOU Minhua, SUN Yan, NI Liu, SHI Xiaoli, SU Xiaoqing, LI Yuqian. Efficacy of Community-involved Hospice Care for Patients with Advanced Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(28): 3573-3584.
[8]	HUANG Qixian, WEN Yanting, HUANG Jun, LI Weibin, XU Yongneng, LIN Xiayi, WANG Haoxiang, WENG Fan, YANG Lianping. Prevalence of Dyslipidemia and Its Influencing Factors among Elderly Community Residents [J]. Chinese General Practice, 2023, 26(28): 3520-3525.
[9]	TIAN Meiling, MA Guojuan, DU Liyan, XIAO Yuange, ZHANG Sai, ZHANG Cui, TANG Zengjun. Prevalence and Epidemiology of Gestational Diabetes Mellitus from 2014 to 2021 in Hebei Province [J]. Chinese General Practice, 2023, 26(26): 3320-3324.
[10]	XUE Shan, LI Laiyou, LIANG Junli, JIN Yinghui, WEI Shuyan. The Efficacy and Safety of Home Enteral Nutrition in Patients with Esophageal Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(20): 2540-2547.
[11]	ZHANG Xingshan, LIN Yue, WAN Chonghua, SONG Aifeng, PAN Haiyan. A Nephrotic Syndrome-specific Quality of Life Scale: Development Based on the Quality of Life Instruments for Chronic Diseases, and Verification Using the Classical Test Theory [J]. Chinese General Practice, 2023, 26(20): 2488-2495.
[12]	SUN Xuhai, SHI Xiuxiu, ZHAO Zhengzheng, HAN Jinxiang. Characteristics of Newly Increased and Deceased Patients with Severe Mental Illness in a Community in Beijing from 2011 to 2021 [J]. Chinese General Practice, 2023, 26(19): 2402-2407.
[13]	LI Peiwen, HE Jiahui, MA Ximin, QIAO Hui. Health-related Quality of Life Measured Using the EQ-5D-3L and Health Service Utilization in Rural Residents of Ningxia [J]. Chinese General Practice, 2023, 26(19): 2361-2368.
[14]	LIU Lu, JIANG Yunlan, PENG Hanmei, LU Yutong, LIU Mingting, LIAO Shiqin. Dysphagia Incidence after Cardiac Surgery: a Meta-analysis [J]. Chinese General Practice, 2023, 26(18): 2293-2300.
[15]	WU Xiaoyu, WAN Chonghua, CHEN Ying, RUAN Yanqin, WENG Yijie, XU Xiaojiang. A Review of Studies on Patient-reported Outcomes and Disease-specific Health-related Quality of Life Instruments for Irritable Bowel Syndrome [J]. Chinese General Practice, 2023, 26(18): 2268-2276.